CYTK· Cytokinetics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 31 | $16M |
Quarterly ownership history
Last 6 quarters
CYTK Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$10.3B
Enterprise value$10.2B
EV / EBITDA (TTM)-16.21
P/E ratio (TTM)—
Forward P/E-15.80
P/S ratio97.61
P/B ratio-14.34
PEG ratio—
Cash Flow
Operating cash flow (TTM)-$524M
Free cash flow (TTM)-$381M
Total cash$819M
Total debt$1.4B
Debt / equity—
Current ratio4.21
Income Statement
Total revenue (TTM)$106M
Revenue per share (TTM)0.87
Gross profit (TTM)-$308M
EBITDA (TTM)-$629M
Net income (TTM)-$830M
EPS diluted (TTM)-6.85
Shares outstanding134,291,720
Float shares123,880,084
Profitability
Gross margin-290.73%
Operating margin-948.69%
EBITDA margin0.00%
Net margin0.00%
Efficiency
Return on assets (TTM)-31.54%
Return on equity (TTM)—
Price History
Current price$76.91
52 Week high$80.20
52 Week low$29.31
50 day average$64.49
200 day average$58.54
Average volume (10 day)5,124,220
1-year beta0.38
1-year price target$104.00
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:37 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com